ClearPoint Neuro, Inc. Schedule 13G shows that MAK Capital Fund LP, MAK Capital One L.L.C. and Michael A. Kaufman beneficially own 1,729,611 shares of Common Stock, representing 6.1% of the class as of 03/13/2026. The filing reports shared voting and dispositive power over those shares. The excerpt cites 28,423,308 shares outstanding as of October 27, 2025 per the issuer's Form 10-Q.
Positive
None.
Negative
None.
Insights
MAK group holds a notable passive stake with shared control.
MAK Capital Fund LP, MAK Capital One L.L.C., and Michael A. Kaufman report beneficial ownership of 1,729,611 shares (6.1%) with shared voting and dispositive power as of 03/13/2026. The filing is a standard Schedule 13G disclosure for large passive holders.
Cash‑flow treatment and any planned transactions are not stated in the excerpt; subsequent filings would show changes. The holder's shared control indicates decisions may involve multiple reporting entities; monitor future ownership filings for any change in voting or disposition patterns.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
ClearPoint Neuro, Inc.
(Name of Issuer)
Common Stock, $0.01 par value per share
(Title of Class of Securities)
03/10/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP Number(s):
1
Names of Reporting Persons
MAK Capital Fund LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
BERMUDA
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,729,611.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,729,611.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,729,611.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.1 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: The calculation is based upon 1,729,611 shares of Common Stock beneficially owned as of 03/13/2026 and a total of 28,423,308 shares of Common Stock, $0.01 par value per share, outstanding as of October 27, 2025, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 6, 2025.
SCHEDULE 13G
CUSIP Number(s):
1
Names of Reporting Persons
MAK CAPITAL ONE LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,729,611.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,729,611.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,729,611.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.1 %
12
Type of Reporting Person (See Instructions)
IA
Comment for Type of Reporting Person: The calculation is based upon 1,729,611 shares of Common Stock beneficially owned as of 03/13/2026 and a total of 28,423,308 shares of Common Stock, $0.01 par value per share, outstanding as of October 27, 2025, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 6, 2025.
SCHEDULE 13G
CUSIP Number(s):
1
Names of Reporting Persons
Kaufman Michael A
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,729,611.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,729,611.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,729,611.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.1 %
12
Type of Reporting Person (See Instructions)
IN
Comment for Type of Reporting Person: The calculation is based upon 1,729,611 shares of Common Stock beneficially owned as of 03/13/2026 and a total of 28,423,308 shares of Common Stock, $0.01 par value per share, outstanding as of October 27, 2025, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 6, 2025.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
ClearPoint Neuro, Inc.
(b)
Address of issuer's principal executive offices:
120 S. SIERRA AVENUE, SUITE 100, SOLANA BEACH, CALIFORNIA, 92075.
Item 2.
(a)
Name of person filing:
This Schedule 13G is being filed by:
i. MAK Capital Fund LP ("MAK Fund")
ii. MAK Capital One L.L.C. ("MAK Capital"); and
iii. Michael A. Kaufman ("Mr. Kaufman," and collectively with MAK Fund and MAK Capital, the "Reporting Persons")
(b)
Address or principal business office or, if none, residence:
The principal business address of (i) MAK Fund is c/o Wakefield Quin, Victoria Place, 31 Victoria Street, Bermuda; and (ii) MAK Capital and Mr. Kaufman is 590 Madison Avenue, 31st Floor, New York, NY 10022.
(c)
Citizenship:
MAK Capital Fund LP is a Bermuda limited partnership.
MAK Capital One L.L.C. is a Delaware limited liability company.
Mr. Kaufman is a United States citizen.
(d)
Title of class of securities:
Common Stock, $0.01 par value per share
(e)
CUSIP No.:
18507C103
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
1,729,611
(b)
Percent of class:
6.1%
The calculation is based upon 1,729,611 shares of Common Stock beneficially owned as of 03/13/2026 and a total of 28,423,308 shares of Common Stock, $0.01 par value per share, outstanding as of October 27, 2025, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 6, 2025.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
1,729,611
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
1,729,611
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
What stake does MAK Capital report in ClearPoint Neuro (CLPT)?
MAK Capital reports beneficial ownership of 1,729,611 shares, equal to 6.1% of ClearPoint Neuro's common stock as of 03/13/2026. The filing cites 28,423,308 shares outstanding as of October 27, 2025, per the issuer's Form 10-Q.
Who are the reporting persons on the Schedule 13G for CLPT?
MAK Capital Fund LP, MAK Capital One L.L.C., and Michael A. Kaufman are listed as the reporting persons. The filing shows MAK Fund (Bermuda), MAK Capital (Delaware), and Mr. Kaufman (United States) as the entities/persons reporting the beneficial ownership.
Does the Schedule 13G indicate sole voting or dispositive power?
The filing states the reporting persons have no sole voting or dispositive power and instead report shared voting and shared dispositive power over 1,729,611 shares. This indicates control is shared among the named reporting persons.
What is the reference date for the outstanding share count in the filing?
The filing cites a total of 28,423,308 shares outstanding as of October 27, 2025, referencing the issuer's Quarterly Report on Form 10-Q filed on November 6, 2025. The beneficial‑ownership calculation uses that outstanding count.
